SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-004500
Filing Date
2020-01-16
Accepted
2020-01-16 08:49:38
Documents
3
Period of Report
2020-01-16
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm203495d1_8k.htm 8-K 34903
2 EXHIBIT 3.1 tm203495d1_ex3-1.htm EX-3.1 6766
3 EXHIBIT 3.2 tm203495d1_ex3-2.htm EX-3.2 90887
  Complete submission text file 0001104659-20-004500.txt   134240
Mailing Address ONE WALL STREET FLOOR 6 BURLINGTON MA 01803
Business Address ONE WALL STREET FLOOR 6 BURLINGTON MA 01803 781-994-0300
ARQULE INC (Filer) CIK: 0001019695 (see all company filings)

IRS No.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21429 | Film No.: 20529522
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences